Clinical Trial

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-06; most recent amendment 2025-11-04.
Status change: Not Yet Recruiting → Recruiting 2025-11-04
Trial Details
NCT Number NCT07121972
Lead Sponsor University of California, San Francisco
Collaborators: Breast Cancer Research Foundation
Conditions Cancer Risk, Breast Cancer Risk
Enrollment 400 participants
Start Date 2025-11-03
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-06